Eazemyapi ist eine No-Code-Plattform, die Gründern, Entwicklern und Startups ermöglicht, sichere, skalierbare Backend-APIs zu erstellen und KI-Modelle in wenigen Minuten zu integrieren. Es eliminiert die Notwendigkeit manueller Datenbankeinrichtung und wiederholter Codierung und ermöglicht eine schnelle Produktentwicklung und -bereitstellung.
Xano ist eine skalierbare No-Code-Backend-Plattform, die Entwickler und Teams befähigt, produktionsreife Anwendungen und KI-Agenten in AI-Geschwindigkeit zu erstellen. Sie bietet eine einheitliche Lösung für APIs, eine verwaltete Postgres-Datenbank, visuelle Logik und eine automatisch skalierende Infrastruktur, wodurch komplexe DevOps überflüssig werden.
Eazemyapi ist eine No-Code-Plattform, die Gründern, Entwicklern und Startups ermöglicht, sichere, skalierbare Backend-APIs zu erstellen und KI-Modelle in wenigen Minuten zu integrieren. Es eliminiert die Notwendigkeit manueller Datenbankeinrichtung und wiederholter Codierung und ermöglicht eine schnelle Produktentwicklung und -bereitstellung.
Xano ist eine skalierbare No-Code-Backend-Plattform, die Entwickler und Teams befähigt, produktionsreife Anwendungen und KI-Agenten in AI-Geschwindigkeit zu erstellen. Sie bietet eine einheitliche Lösung für APIs, eine verwaltete Postgres-Datenbank, visuelle Logik und eine automatisch skalierende Infrastruktur, wodurch komplexe DevOps überflüssig werden.
| Feature | Eazemyapi | Xano |
|---|---|---|
| Hauptkategorie | API-Integration | Agentenentwicklung |
| Hinzugefügt | 2025-11-15 | 2025-10-24 |
| Preismodell | Freemium | Freemium |
| Offizielle Website | www.eazemyapi.com | www.xano.com |
| Produkttyp | Website | Website |
| Performance data | ||
| Nutzerbewertung | Nicht verifiziert | Nicht verifiziert |
| Kommentare | 0 | 0 |
| Monatliche Besuche | 4.5K | 171.8K |
| Monatliches Wachstum | Nicht verifiziert | -10.6% |
| Favoriten | 134 | 137 |
| Details | Details ansehen | Details ansehen |
Compare Eazemyapi and Xano by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the Eazemyapi vs Xano monthly traffic comparison, Eazemyapi currently shows 4.5K visits and Xano shows 171.8K; Xano has about 38.3 times the visible traffic of Eazemyapi, an absolute difference of about 167.3K visits. This reflects visible reach, not feature quality or paid users.
Only Xano has complete third-party traffic details; Eazemyapi uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 38.34% | 65.9K |
| 🇧🇷Brazil | 22.87% | 39.3K |
| 🇹🇭Thailand | 13.92% | 23.9K |
| 🇫🇷France | 12.79% | 22K |
| 🇪🇸Spain | 12.08% | 20.8K |
| Source type | Percentage | Traffic |
|---|---|---|
| Verweis | 50.12% | 86.1K |
| Direkt | 47.64% | 81.9K |
| 2.24% | 3.8K |
This in-depth Eazemyapi vs Xano comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Eazemyapi is primarily listed under “API-Integration”, while Xano is primarily listed under “Agentenentwicklung”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Eazemyapi: API-Integration; Xano: Agentenentwicklung); Monthly visits (Eazemyapi: 4.5K; Xano: 171.8K); Favorites (Eazemyapi: 134; Xano: 137); Website (Eazemyapi: www.eazemyapi.com; Xano: www.xano.com); Added (Eazemyapi: 2025-11-15; Xano: 2025-10-24). These facts are more useful for selection than brand visibility alone.
In the Eazemyapi vs Xano monthly traffic comparison, Eazemyapi currently shows 4.5K visits and Xano shows 171.8K; Xano has about 38.3 times the visible traffic of Eazemyapi, an absolute difference of about 167.3K visits. This reflects visible reach, not feature quality or paid users.
Only Xano has complete third-party traffic details; Eazemyapi uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Eazemyapi and Xano currently overlap in shared tags: Cloud-Hosting, Datenbank, No-Code und Visuelle Entwicklung. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Eazemyapi's unique categories/tags are API-Integration, Datenbank-Tools, API-Entwicklung, Backend-Entwicklung, KI-Integration, API-Builder, AWS RDS und Kreditbasierte Preisgestaltung; Xano's are Agentenentwicklung, API-Builder, Postgres, Backend-Entwicklung, Anwendungsentwicklung, KI-Agenten, KI-Entwicklung und API. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
Eazemyapi has no verified rating, 0 comments, 134 favorites, and 136 likes；Xano has no verified rating, 0 comments, 137 favorites, and 140 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put Eazemyapi on the priority trial list when the task aligns with “API-Integration” and especially API-Integration, Datenbank-Tools, API-Entwicklung, Backend-Entwicklung, KI-Integration und API-Builder, or the users include Data Scientists, Unternehmer, Gründer und Freelancer. This follows recorded positioning and does not imply unlisted capabilities are absent.
Eazemyapi also currently records: pricing is freemium, product type is website, 4.5K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put Xano on the priority trial list when the task aligns with “Agentenentwicklung” and especially Agentenentwicklung, API-Builder, Postgres, Backend-Entwicklung, Anwendungsentwicklung und KI-Agenten, or the users include KI-Ingenieur, Backend-Entwickler, Citizen Developer und Chief Technology Officer. This follows recorded positioning and does not imply unlisted capabilities are absent.
Xano also currently records: pricing is freemium, product type is website, 171.8K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Eazemyapi and Xano, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
